Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs
Launched by KAROLINSKA INSTITUTET · Aug 22, 2022
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating a helpful online tool called an individual Decision Aid (iDA) for people invited to participate in cancer screening programs in Sweden, including screenings for colorectal, breast, and ovarian cancers. The goal of this tool is to provide clear and accurate information about cancer and the screening process, allowing individuals to make informed decisions based on their personal values and preferences rather than fear or misunderstandings. By using the iDA, participants can learn about their options and communicate with healthcare professionals before deciding whether to participate in screening.
To be eligible for this study, women aged 23 to 74 and men aged 60 to 74 can join. There are no specific exclusions, meaning anyone within these age ranges can participate. Those who take part can expect to share their thoughts and experiences through interviews or discussions, helping to shape the tool and evaluate its effectiveness. This trial aims to improve knowledge about cancer screenings in society and ensure that everyone has the information they need to make confident decisions about their health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • women aged 23 -74
- • men aged 60 - 74
- Exclusion Criteria:
- • none
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Huddinge, , Sweden
Patients applied
Trial Officials
Kaisa Fritzell, PhD
Principal Investigator
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials